Butterfly Network
Closed (deSPAC)Profile in progress
- What it is
- Network, Inc
- What it’s doing now
- Merging with Longview Acquisition Corp. (LGVW) — closed (despac).
- What you should know
- Data is still being assembled for this company — what is shown below is everything we have verified so far.
The business, per its filings
SEC primaryNetwork, Inc. Founded by Dr. Jonathan Rothberg in 2011 and listed on the New York Stock Exchange through a business combination with Longview Acquisition Corp., Butterfly created the world's first handheld, single probe whole-body ultrasound system using semiconductor technology, the Butterfly iQ+. Butterfly's mission is to democratize medical imaging and contribute to the aspiration of global health equity, making high-quality ultrasound affordable, easy-to-use, globally accessible, and intelligently connected, including for the 4.7 billion people around the world lacking access to ultrasound. Through its proprietary Ultrasound-on-Chip™ technology, Butterfly is paving the way for earlier detection and remote management of health conditions around the world. The Butterfly iQ+ can be purchased online today by healthcare practitioners in the United States, Australia, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Ireland, Italy, the Netherlands, New Zealand, Norway, Poland, Portugal, Spain, Sweden, Switzerland, and the United Kingdom. Butterfly iQ+ is a prescription device intended for trained healthcare professionals only. Non-GAAP Financial Measures In addition to providing financial measurements based on generally accepted accounting principles in the United States of America (“GAAP”), the Company provides additional financial metrics that are not prepared in accordance with GAAP (“non-GAAP”). The non-GAAP financial measures included in this press release are Adjusted EBITDA, Adjusted gross profit and Adjusted gross margin. The Company presents non-GAAP financial measures in order to assist readers of its condensed consolidated financial statements in understanding the core operating results that its management uses to evaluate the business and for
What the company says about itself
Web research — not auditedButterfly Network provides point-of-care ultrasound (POCUS) solutions, featuring its handheld whole-body probes (Butterfly iQ3 and iQ+), integrated AI, workflow management software, and an education suite. The company serves individual clinicians, health systems, and medical education programs, with over 145,000 customers worldwide.
- Markets:
- Healthcare | Medical devices | Point-of-care ultrasound
- Products:
- Butterfly iQ3 | Butterfly iQ+ | Butterfly Embedded
- Customers:
- Tulane Hypermobility and Ehlers-Danlos Clinic | Medical University of South Carolina | Lewis Katz School of Medicine at Temple University | Cooper University Healthcare | University of Rochester Medical Center
[WEB-INTEL 2026-08-26] 1 finding(s) · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "Butterfly Network had raised more than $400 million from investors, including Baillie Gifford, the Bill and Melinda Gates Foundation, and Fosun Industrial Co., ..." [https://www.mintz.com/industries-practices/case-studies/mintz-represents-butterfly-network-15b-spac-deal]
Source: https://www.butterflynetwork.com/ · captured Aug 26, 2026 · marketing claims are reported as claims, never merged into the filed figures above.
The deal it’s entering
Butterfly Network is merging with Longview Acquisition Corp. (LGVW) currently marked Closed (deSPAC).
| Headline equity value | — |
How to read these numbers: headline vs effective valuation · what a definitive agreement commits
What exactly is being valued, and at what
Common questions
Is Butterfly Network going public?
Butterfly Network has an approved merger with the SPAC Longview Acquisition Corp. (LGVW). Deal status: Closed (deSPAC).
Does Butterfly Network have revenue?
The filings we've parsed don't state a usable revenue figure yet; this profile is updated as new documents land.
Educational content, not investment advice.